Andrew P. Smith
2014
In 2014, Andrew P. Smith earned a total compensation of $570.4K as Former Chief Financial Officer at Sucampo Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $138,053 |
|---|---|
| Option Awards | $108,473 |
| Salary | $285,953 |
| Other | $37,883 |
| Total | $570,362 |
Smith received $286K in salary, accounting for 50% of the total pay in 2014.
Smith also received $138.1K in non-equity incentive plan, $108.5K in option awards and $37.9K in other compensation.
Rankings
In 2014, Andrew P. Smith's compensation ranked 9,844th out of 13,032 executives tracked by ExecPay. In other words, Smith earned more than 24.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,844 out of 13,032 | 25th |
Division Manufacturing | 3,732 out of 4,965 | 25th |
Major group Chemicals And Allied Products | 1,279 out of 1,690 | 24th |
Industry group Drugs | 1,019 out of 1,369 | 26th |
Industry Pharmaceutical Preparations | 780 out of 1,042 | 25th |
Source: SEC filing on April 21, 2017.
Smith's colleagues
We found five more compensation records of executives who worked with Andrew P. Smith at Sucampo Pharmaceuticals in 2014.
2014
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2014
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2014
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2014
Max Donley
Sucampo Pharmaceuticals
EVP, Global Human Resources, Information Technology and Strategy
2014
Peter Lichtlen
Sucampo Pharmaceuticals